Bryce A. Baird
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Bryce A. Baird has a total of 69 co-authors. Here are the top co-authors by number of shared publications:
Augustus Anderson
Department of Urology, Mayo Clinic, Jacksonville, FL
3 shared publicationsChristian A. Ericson
Mayo Clinic Florida, Department of Urology, Jacksonville, FL, USA
3 shared publicationsGregory Broderick
Department of Urology, Mayo Clinic , Jacksonville, FL
3 shared publications- Chandler D. Dora
Department of Urology, Mayo Clinic, Jacksonville, USA
2 shared publications Charles Klose
Department of Urology Mayo Clinic Jacksonville Florida USA
2 shared publications- Eric Qualkenbush
Department of Urology Mayo Clinic Jacksonville Florida USA
2 shared publications
Latest Publications
- 24 August 2026
- Published by Wiley in Lasers in Surgery and Medicine
- Vol. 58 (9) , 877-884
Multicenter Evaluation of Noise Levels and Staff Perceptions Across Laser Technologies During Holmium Laser Enucleation of the Prostate: A Prostate Enucleation Collaborative Initiative
Introduction: Operating room (OR) noise during holmium laser enucleation of the prostate (HoLEP), particularly from laser activation, may impair surgical workflow and staff performance. Methods: 84 HoLEP procedures were recorded at three academic institutions between June 2024 and January 2026. Laser platforms included Lumenis Moses 2.0, Quanta Litho 150, Quanta Magneto, and Dornier Thulio. Sound measurements were obtained using a standardized smartphone‐based system during three phases: laser‐off (baseline), idle (not firing), and active lasing. Acoustic metrics included average sound level (LAeq), peak sound level (Lcpeak), and sound levels exceeded for 10%, 50%, and 90% of the recording time (L10, L50, and L90). Background noise correction was performed using baseline measurements to account for ambient noise and isolate laser‐related sound. OR staff completed a validated survey assessing perceived noise burden (0–10 scale). Results: Background‐corrected noise during active lasing differed significantly by platform. Litho demonstrated lower mean noise levels compared to Thulio for LAeq (60.6 vs. 68.2 dB, p = 0.023) and L10 (61.5 vs. 70.6 dB, p = 0.023), while Moses had higher LAeq compared to Litho (63.1 vs. 60.6 dB, p = 0.043). Overall, Litho had the lowest noise levels, whereas Thulio had the highest. Survey responses paralleled these findings. Litho was associated with lower perceived overall effort (2.1 ± 0.9), while Moses demonstrated higher overall effort (3.6 ± 1.2) for communication and concentration (Figure 2). Significant pairwise differences were observed between Moses and Litho (all p < 0.05). Trends were consistent across sites. Conclusions: Noise levels during HoLEP varied by laser technology and correlated with differences in perceived communication and cognitive effort. Litho demonstrated the lowest acoustic burden, while Moses and Thulio had higher noise exposure. These findings highlight the impact of laser selection on the OR environment and intraoperative team performance.
- 24 August 2026
- Published by Wiley in Lasers in Surgery and Medicine
- Vol. 58 (9) , 877-884
Multicenter Evaluation of Noise Levels and Staff Perceptions Across Laser Technologies During Holmium Laser Enucleation of the Prostate: A Prostate Enucleation Collaborative Initiative
Introduction: Operating room (OR) noise during holmium laser enucleation of the prostate (HoLEP), particularly from laser activation, may impair surgical workflow and staff performance. Methods: 84 HoLEP procedures were recorded at three academic institutions between June 2024 and January 2026. Laser platforms included Lumenis Moses 2.0, Quanta Litho 150, Quanta Magneto, and Dornier Thulio. Sound measurements were obtained using a standardized smartphone‐based system during three phases: laser‐off (baseline), idle (not firing), and active lasing. Acoustic metrics included average sound level (LAeq), peak sound level (Lcpeak), and sound levels exceeded for 10%, 50%, and 90% of the recording time (L10, L50, and L90). Background noise correction was performed using baseline measurements to account for ambient noise and isolate laser‐related sound. OR staff completed a validated survey assessing perceived noise burden (0–10 scale). Results: Background‐corrected noise during active lasing differed significantly by platform. Litho demonstrated lower mean noise levels compared to Thulio for LAeq (60.6 vs. 68.2 dB, p = 0.023) and L10 (61.5 vs. 70.6 dB, p = 0.023), while Moses had higher LAeq compared to Litho (63.1 vs. 60.6 dB, p = 0.043). Overall, Litho had the lowest noise levels, whereas Thulio had the highest. Survey responses paralleled these findings. Litho was associated with lower perceived overall effort (2.1 ± 0.9), while Moses demonstrated higher overall effort (3.6 ± 1.2) for communication and concentration (Figure 2). Significant pairwise differences were observed between Moses and Litho (all p < 0.05). Trends were consistent across sites. Conclusions: Noise levels during HoLEP varied by laser technology and correlated with differences in perceived communication and cognitive effort. Litho demonstrated the lowest acoustic burden, while Moses and Thulio had higher noise exposure. These findings highlight the impact of laser selection on the OR environment and intraoperative team performance.
- 4 November 2025
- Published by Springer Nature in World Journal of Urology
- Vol. 43 (1) , 1-4
Pre and post cystoscopy pain in patients undergoing first office based flexible cystoscopy
Purpose We aim to evaluate the patient-anticipated degree of pain versus the experienced degree of pain before and after cystoscopy in patients undergoing their first outpatient cystoscopy. Methods We studied 39 patients who underwent their first office-based cystoscopy. All cystoscopies were performed with the disposable Ambu aScope 4. Anticipated cystoscopy-associated pain was judged with a pre-procedural score, and pain experienced during the cystoscopy was judged with a post-procedural score. All patients graded their pre- and post-cystoscopy pain using a standard 10-point scale (0–10). Results Medians and interquartile ranges the patients’ age [65 years (54.5–68.0)], pre-procedural pain [7 (5–8)], and post-procedural pain [2 (1–3)] were recorded. Thirty (77%) patients were male and nine patients (23%) were female. The average pre-procedural prediction pain score was 6.56 ± 2.18; the average post-procedural perceived pain score was 2.36 ± 1.72 (P < 0.05). There was an average decrease of over 4 points in predicted pain vs. perceived pain. There was no significant difference observed between expected (p = 0.84) or experienced (p = 0.59) pain scores between male and female patients. There was also no observed difference based on age, when comparing patients 65 and younger to those older than 65 years of age (expected p = 0.18, experienced p = 0.19). Conclusion Patients experience significantly less pain with outpatient cystoscopy than they anticipate having. This study will be helpful when counseling patients about the use of cystoscopy to evaluate urologic pathologies.
- 4 November 2025
- Published by Springer Nature in World Journal of Urology
- Vol. 43 (1) , 1-4
Pre and post cystoscopy pain in patients undergoing first office based flexible cystoscopy
Purpose We aim to evaluate the patient-anticipated degree of pain versus the experienced degree of pain before and after cystoscopy in patients undergoing their first outpatient cystoscopy. Methods We studied 39 patients who underwent their first office-based cystoscopy. All cystoscopies were performed with the disposable Ambu aScope 4. Anticipated cystoscopy-associated pain was judged with a pre-procedural score, and pain experienced during the cystoscopy was judged with a post-procedural score. All patients graded their pre- and post-cystoscopy pain using a standard 10-point scale (0–10). Results Medians and interquartile ranges the patients’ age [65 years (54.5–68.0)], pre-procedural pain [7 (5–8)], and post-procedural pain [2 (1–3)] were recorded. Thirty (77%) patients were male and nine patients (23%) were female. The average pre-procedural prediction pain score was 6.56 ± 2.18; the average post-procedural perceived pain score was 2.36 ± 1.72 (P < 0.05). There was an average decrease of over 4 points in predicted pain vs. perceived pain. There was no significant difference observed between expected (p = 0.84) or experienced (p = 0.59) pain scores between male and female patients. There was also no observed difference based on age, when comparing patients 65 and younger to those older than 65 years of age (expected p = 0.18, experienced p = 0.19). Conclusion Patients experience significantly less pain with outpatient cystoscopy than they anticipate having. This study will be helpful when counseling patients about the use of cystoscopy to evaluate urologic pathologies.
- Open Access
- 21 June 2024
- Published by Elsevier in Urology Case Reports
- Vol. 56, 102775
Conservative management of segmental testicular infarction in a patient with sickle cell anemia: A case report
- 21 June 2024
- Published by Elsevier in Urology Case Reports
- Vol. 56, 102775
Open AccessConservative management of segmental testicular infarction in a patient with sickle cell anemia: A case report
- Open Access
- 19 October 2022
- Published by Elsevier in Urology Case Reports
- Vol. 45, 102263
A rare case of BK virus non-hemorrhagic cystitis following lung transplant
- 19 October 2022
- Published by Elsevier in Urology Case Reports
- Vol. 45, 102263
Open AccessA rare case of BK virus non-hemorrhagic cystitis following lung transplant
- Open Access
- 16 September 2022
- Published by Elsevier in Urology Case Reports
- Vol. 45, 102230
Prostatic urethral lift (PUL) clip causing postoperative pain after holmium laser enucleation of the prostate (HoLEP)
- 16 September 2022
- Published by Elsevier in Urology Case Reports
- Vol. 45, 102230
Open AccessProstatic urethral lift (PUL) clip causing postoperative pain after holmium laser enucleation of the prostate (HoLEP)
- Open Access
- 17 March 2022
- Published by Elsevier in Urology Case Reports
- Vol. 43, 102054
Robotic transvesical bladder leiomyoma excision
- 17 March 2022
- Published by Elsevier in Urology Case Reports
- Vol. 43, 102054
Open AccessRobotic transvesical bladder leiomyoma excision
- 26 February 2022
- Published by Oxford University Press (OUP) in The Journal of Sexual Medicine
- Vol. 19 (4) , 590-593
Pre- and Post-Injection Needle Pain in Patients Undergoing First Intracavernosal Injection
Background: Intracavernosal injections (ICI) are a well-established treatment option for men with erectile dysfunction (ED); however, the anticipation of pain with injection remains a significant barrier to the use of ICI.Aim: To evaluate the patient-anticipated degree of pain versus the experienced degree of pain pre- and post-ICI in men undergoing their first injection with an erectile agent.Methods: We studied 51 patients who underwent their first ICI in our men’s health clinic. Anticipated needle-associated pain was judged with a pre-injection score, and pain experienced during the injection was judged with a post-injection score. All patients graded their pre- and post-ICI pain using a standard 10-point scale (0–10).Outcomes: Pre- and post-ICI pain was defined with the visual analogue scale (0–10) in men undergoing their first penile injection.Results: Medians and interquartile ranges (IQRs) of the patients’ age [65 years (54.5–68.0)], pre-injection pain [5 (4–7)], and post-injection pain [1 (1–2)] were recorded. Most men in the study had erectile dysfunction (68.6%) and/or Peyronie’s Disease (64.7%). The average pre-injection prediction pain score was 5.45 ± 2.15; the average post-injection perceived pain score was 1.20 ± 0.73. Thus, there was an average discrepancy of over 4 points in predicted pain vs perceived pain. A paired t-test was performed which showed a statistically significant difference between pre- and post-injection scores (P < .05). A Wilcoxson Signed Rank Test showed statistical significance in the difference between pre- and post-injection pain scores (P < .05).Clinical Implications: ICI is a safe, effective treatment for patients with ED and is associated with significantly less pain than is anticipated by patients.Strengths & Limitations: This is the first report to describe the discrepancy between pre-ICI anticipated pain and post-ICI experienced pain. Limitations include an overall small sample size.Conclusion: Patients experience significantly less pain with ICI than they anticipate having. This represents an important factor to consider when counseling patients about available ED treatments.
- 26 February 2022
- Published by Oxford University Press (OUP) in The Journal of Sexual Medicine
- Vol. 19 (4) , 590-593
Pre- and Post-Injection Needle Pain in Patients Undergoing First Intracavernosal Injection
Background: Intracavernosal injections (ICI) are a well-established treatment option for men with erectile dysfunction (ED); however, the anticipation of pain with injection remains a significant barrier to the use of ICI.Aim: To evaluate the patient-anticipated degree of pain versus the experienced degree of pain pre- and post-ICI in men undergoing their first injection with an erectile agent.Methods: We studied 51 patients who underwent their first ICI in our men’s health clinic. Anticipated needle-associated pain was judged with a pre-injection score, and pain experienced during the injection was judged with a post-injection score. All patients graded their pre- and post-ICI pain using a standard 10-point scale (0–10).Outcomes: Pre- and post-ICI pain was defined with the visual analogue scale (0–10) in men undergoing their first penile injection.Results: Medians and interquartile ranges (IQRs) of the patients’ age [65 years (54.5–68.0)], pre-injection pain [5 (4–7)], and post-injection pain [1 (1–2)] were recorded. Most men in the study had erectile dysfunction (68.6%) and/or Peyronie’s Disease (64.7%). The average pre-injection prediction pain score was 5.45 ± 2.15; the average post-injection perceived pain score was 1.20 ± 0.73. Thus, there was an average discrepancy of over 4 points in predicted pain vs perceived pain. A paired t-test was performed which showed a statistically significant difference between pre- and post-injection scores (P < .05). A Wilcoxson Signed Rank Test showed statistical significance in the difference between pre- and post-injection pain scores (P < .05).Clinical Implications: ICI is a safe, effective treatment for patients with ED and is associated with significantly less pain than is anticipated by patients.Strengths & Limitations: This is the first report to describe the discrepancy between pre-ICI anticipated pain and post-ICI experienced pain. Limitations include an overall small sample size.Conclusion: Patients experience significantly less pain with ICI than they anticipate having. This represents an important factor to consider when counseling patients about available ED treatments.